title: Gene expression of prothrombin in human and rat kidneys: basic and clinical approach.
abstract: Prothrombin has remarkable affinity for calcium oxalate crystals. It is produced in renal tubular cells and is detected as a urinary form of prothrombin F1. The aim of this basic study was (1) to isolate prothrombin mRNA from normal human and rat kidneys; (2) to confirm expression level changes in stone-forming rat kidneys; and (3) to analyze the DNA sequence of renal prothrombin. The aim of the clinical investigation was to measure the serum levels of renal prothrombin in clinical cases of various urologic diseases. The expression of prothrombin mRNA in human kidneys and male Wistar rat kidneys was investigated using reverse transcription-PCR, with prothrombin (F1, F2, and thrombin) primers. Renal prothrombin levels were measured in the sera of patients with renal cell carcinoma, renal transplant donors, patients with chronic renal failure, and renal transplant recipients, using an enzyme-linked immunosorbent assay. Expression of cyclophilin as well as prothrombin mRNA could be detected. Prothrombin mRNA expression levels seemed to be increased in stone-forming rats. The DNA sequence of renal prothrombin differed from that of liver prothrombin at three points. Repeated measurements of renal prothrombin showed that values were high during the acute tubular necrosis period and tended to decrease with the recovery of renal function. Prothrombin mRNA expression could be confirmed in human and rat kidneys, as well as in stone-forming rat kidneys. Serum concentration measurements can be considered useful for assessment of recovery from acute tubular necrosis after renal transplantation and for diagnosis of acute rejection.
authors.affiliation: Department of Urology, Kanazawa Medical University, Ishikawa, Japan. ksuzuki@kanazawa-med.ac.jp
authors.forename: K
authors.initials: K
authors.lastname: Suzuki
authors.forename: T
authors.initials: T
authors.lastname: Tanaka
authors.forename: K
authors.initials: K
authors.lastname: Miyazawa
authors.forename: C
authors.initials: C
authors.lastname: Nakajima
authors.forename: M
authors.initials: M
authors.lastname: Moriyama
authors.forename: K
authors.initials: K
authors.lastname: Suga
authors.forename: M
authors.initials: M
authors.lastname: Murai
authors.forename: J
authors.initials: J
authors.lastname: Yano
mesh_terms: D000328:Adult; D000818:Animals; D002102:Cadaver; D005260:Female; D006084:Graft Rejection; D006801:Humans; D007668:Kidney / Q000737:chemistry / Q000378:metabolism*; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D011516:Prothrombin / Q000032:analysis / Q000235:genetics*; D012333:RNA, Messenger / Q000032:analysis*; D051381:Rats; D017208:Rats, Wistar
chemical_list: D012333:RNA, Messenger; D011516:Prothrombin